Another study showed that CD162 expressed by multiple myeloma cells was involved in their growth, dissemination, and drug resistance, however, this was through interaction with P-selectin, not E-selectin (Azab et al., 2012). The gene discussed is SELP; the disease is plasma cell myeloma.